Table 4 Biomarkers significant for feature F3, ranked by effect size
From: Case-control Indian buffet process identifies biomarkers of response to Codrituzumab
Continuous Variables | Effect Size | p-value |
|---|---|---|
CD56dimCD16bright | 1.27 | 2.18e-09 |
NK | 1.24 | 2.13e-10 |
CD56-CD16+ | 0.61 | 2.19e-06 |
CD56dimCD16- | 0.42 | 1.04e-05 |
CD8 NK | 0.37 | 7.13e-08 |
DN | 0.27 | 3.73e-05 |
CD16 | 0.24 | 6.06e-10 |
NKP46 | 0.22 | 1.14e-09 |
CD8 | 0.20 | 3.44e-09 |
CD45 | 0.14 | 5.09e-11 |
CD3 | 0.13 | 1.49e-08 |
CD4 | 0.12 | 5.06e-06 |